Q1 has a bunch of deals nearing completion. We could see a couple of intra-review changes before the announcement of the March rebal. I expect we may see "filler" inclusions rather than splashy ones.
What is covered in the Full Insight:
Introduction
Index Selection Criteria
Potential Intra-Review Changes
Leaderboard Analysis
Conclusions
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.